Tarsus Pharmaceuticals
The Medical Science Liaison (MSL) at Tarsus Pharmaceuticals will serve as a field‑based scientific liaison to optometrists and ophthalmologists, delivering compliant education and scientific exchange on eye‑care disease states. The role involves managing KOL relationships, gathering insights, and supporting clinical and medical affairs initiatives across a multi‑state territory.
Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel therapies for diseases with high unmet need, with a primary focus on eye care. The company markets XDEMVY® (lotilaner ophthalmic solution) 0.25%, the first and only FDA-approved treatment for Demodex blepharitis, and has a pipeline targeting conditions such as ocular rosacea and Lyme disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tarsus Pharmaceuticals.
50% above the average for this role
Medical Science Liaison/Senior Medical Science Liaison
EVERSANA
Medical Science Liaison/Senior Medical Science Liaison
EVERSANA
Medical Science Liaison/Senior Medical Science Liaison
EVERSANA
(Sr.) Medical Science Liaison – Anti-Infectives
Azurity Pharmaceuticals
Medical Science Liaison (MSL) / Senior Medical Science Liaison (Sr. MSL)
Celldex Therapeutics
Medical Science Liaison (MSL or Sr. MSL)
Eisai